Marrone Bio Innovations

Marrone Bio Innovations Documents

Documents

100

Ticker

MBII

ISIN

US57165B1061

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

Marrone Bio Innovations SEC Filings

Type
Report
Date
S-8 POSS-8 POS-Formular8/4/2022
S-8 POSS-8 POS-Formular8/4/2022
POS AMPOS AM-Formular8/4/2022
S-8 POSS-8 POS-Formular8/4/2022
S-8 POSS-8 POS-Formular8/4/2022
POS AMPOS AM-Formular8/4/2022
S-8 POSS-8 POS-Formular8/4/2022
POS AMPOS AM-Formular8/4/2022
S-8 POSS-8 POS-Formular8/4/2022
S-8 POSS-8 POS-Formular8/4/2022
POS AMPOS AM-Formular8/4/2022
S-8 POSS-8 POS-Formular8/4/2022
POS AMPOS AM-Formular8/4/2022
4Insidertransaktion7/15/2022
4Insidertransaktion7/15/2022
SC 13D/ASC 13D/A-Formular7/15/2022
4Insidertransaktion7/15/2022
4Insidertransaktion7/14/2022
4Insidertransaktion7/14/2022
4Insidertransaktion7/14/2022
4Insidertransaktion7/14/2022
4Insidertransaktion7/14/2022
4Insidertransaktion7/14/2022
4Insidertransaktion7/14/2022
4Insidertransaktion7/14/2022
4Insidertransaktion7/14/2022
4Insidertransaktion7/14/2022
4Insidertransaktion7/14/2022
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben7/13/2022
25-NSE25-NSE-Formular7/12/2022
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben7/11/2022
4Insidertransaktion7/7/2022
4Insidertransaktion7/5/2022
4Insidertransaktion7/5/2022
4Insidertransaktion7/5/2022
4Insidertransaktion7/5/2022
4Insidertransaktion7/5/2022
4Insidertransaktion7/5/2022
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben6/30/2022
4Insidertransaktion6/13/2022
DEFM14ADEFM14A-Formular6/9/2022
4Insidertransaktion5/25/2022
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/19/2022
10-QQuartalsbericht5/13/2022
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/11/2022
10-K/A10-K/A-Formular5/9/2022
10-K/A10-K/A-Formular4/29/2022
4Insidertransaktion4/8/2022
4Insidertransaktion4/8/2022
4Insidertransaktion4/8/2022
4Insidertransaktion4/8/2022
4Insidertransaktion4/8/2022
4Insidertransaktion4/8/2022
10-KJahresbericht3/30/2022
SC 13G/ABeneficial ownership report3/29/2022
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben3/28/2022
4Insidertransaktion3/28/2022
33-Formular3/24/2022
425425-Formular3/23/2022
4/A4/A-Formular3/18/2022
4/A4/A-Formular3/18/2022
4/A4/A-Formular3/18/2022
4/A4/A-Formular3/18/2022
4/A4/A-Formular3/18/2022
4/A4/A-Formular3/18/2022
425425-Formular3/18/2022
425425-Formular3/18/2022
425425-Formular3/18/2022
425425-Formular3/17/2022
425425-Formular3/17/2022
425425-Formular3/16/2022
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben3/16/2022
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/22/2022
SC 13G/ABeneficial ownership report2/14/2022
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/10/2022
4Insidertransaktion2/9/2022
4Insidertransaktion2/9/2022
4Insidertransaktion2/9/2022
4Insidertransaktion2/9/2022
4Insidertransaktion2/9/2022
4Insidertransaktion2/9/2022
SC 13GSC 13G-Formular2/8/2022
55-Formular1/25/2022
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/18/2022
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/6/2022
4Insidertransaktion1/4/2022
4Insidertransaktion1/4/2022
4Insidertransaktion1/4/2022
4Insidertransaktion1/4/2022
4Insidertransaktion1/4/2022
4Insidertransaktion1/4/2022
4Insidertransaktion12/17/2021
SC 13D/ASC 13D/A-Formular12/17/2021
4Insidertransaktion11/15/2021
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/10/2021
SC 13G/ABeneficial ownership report11/10/2021
10-QQuartalsbericht11/10/2021
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/8/2021
33-Formular10/5/2021
4Insidertransaktion10/4/2021

Marrone Bio Innovations Documents 2026

This page contains all official documents and SEC filings for Marrone Bio Innovations stock (MBII, ISIN: US57165B1061). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 100 documents are available. Data is updated regularly to provide investors with a complete overview of Marrone Bio Innovations's regulatory filings.

Marrone Bio Innovations Stock analysis

Marrone Bio Innovations Marrone Bio Innovations Inc is an American company that has been operating in the field of biological pest control since 2006. It was founded by chemist Dr. Pamela Marrone and is headquartered in Davis, California. The company's business model is based on developing safe and effective biological pest control products made from natural ingredients. The aim is to minimize the environmental impact of agriculture. The company is divided into different divisions, including biological plant protection, biological nitrogen fixation, biological weed control, and other products. Some of the well-known products include Regalia®, Venerate®, and Majestene®. Marrone Bio Innovations has gained significance in recent years and is now one of the leading companies in the field of biological pest control. The company works closely with farmers, research institutions, and regulatory authorities to develop and introduce new products, always prioritizing safety and environmental compatibility.